The popularity of viral vector-based gene therapies and vaccines is rapidly growing. However, it is often difficult for scientists to ramp up the generation of these vectors to meet their needs at each stage of development. Researchers require scalable manufacturing strategies to support the advanced production of viral vectors for these clinical applications.
Download this application note from Thermo Fisher Scientific to learn how scientists have used their lentiviral production system, single-use bioreactors, and clarification products to generate lentiviral vectors at the 50-liter scale.
